PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Bioinformatics and Computational Biophysics, Faculty of Biology and Centre for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, 45141, Germany.\', \'Institute of Virology, University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, 50935, Germany.\', \'Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, 14080, Mexico.\', \'Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, 40225, Germany.\', \'Institute of Medical Microbiology and Hygiene, Saarland University Medical Center, Homburg, 66421, Germany.\', \'Computational Biology, Max Planck Institute for Informatics, Saarland Informatics Campus, Saarbrücken, 66123, Germany.\', \'Bioinformatics and Computational Biophysics, Faculty of Biology and Centre for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, 45141, Germany. daniel.hoffmann@uni-due.de.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s12889-021-11178-w
?:doi
?:hasPublicationType
?:journal
  • BMC public health
is ?:pmid of
?:pmid
?:pmid
  • 34154549
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.337
?:rankingScore_hIndex
  • 103
?:title
  • Rhinovirus prevalence as indicator for efficacy of measures against SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all